ICD-10-CM Billable Code

H04.15

Secondary lacrimal gland atrophy

Clinical Classification Guidelines

Medical Intelligence & Overview

Secondary lacrimal gland atrophy is a condition where the tear-producing glands located in the eyelids become weakened or shrink over time, leading to decreased tear production. This can result in dry eyes and discomfort, impacting daily activities and eye health. The term 'secondary' indicates that the atrophy is caused by another health issue or injury rather than occurring spontaneously.

Causes & Symptoms

Clinical Causes: Chronic inflammation or infection affecting the lacrimal gland Autoimmune diseases such as Sjögren's syndrome Trauma or injury to the eyelid or eye area Radiation therapy near the face or eyes Long-term use of certain medications that impact tear production Degenerative conditions or aging processes

Key Symptoms: Persistent dryness in the eyes A sensation of grittiness or foreign body in the eye Redness and irritation Blurred or decreased vision Increased sensitivity to light Excessive tearing as the eyes try to compensate for dryness

Diagnostic & Treatment

Diagnosis Path: Diagnosis involves a comprehensive eye examination, including assessment of tear production, usually measured via Schirmer's test. Imaging studies like MRI or ultrasound might be used to evaluate the lacrimal gland’s size and structure. A detailed medical history helps identify underlying causes such as autoimmune diseases or previous trauma. Sometimes, laboratory tests are performed to detect systemic conditions contributing to gland atrophy.

Treatment Protocols: Treatment options focus on alleviating symptoms and addressing underlying causes. These may include:

Reimbursement claims with a date of service on or after October 1, 2015 require the use of ICD-10-CM codes.

Clinical Advice & FAQs

Billing Guidance

Is H04.15 a billable ICD-10 code?
Yes, H04.15 is a specific, billable code that can be used to indicate a diagnosis for reimbursement purposes.

Documentation

How do I report H04.15?
Clinical documentation must specify the nature of Secondary lacrimal gland atrophy and any associated comorbidities for accurate reporting.

Cite this Clinical Reference